Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vivek Subbiah

Showing results (121-130 of 487) with videos related to

Pageof 49
Sort By:
Mayo Clinic Proceedings|November 6, 2020
Patient-Centered, Physician-Investigator Friendly Pragmatic Phase Trial Designs-The 4P ModelDavid C Norris, Shiraj Sen, Roman Groisberg, et al.
JCO Precision Oncology|November 6, 2020
Systemic and CNS Activity of Selective RET Inhibition With Selpercatinib (LOXO-292) in a Patient With RET-Mutant Medullary Thyroid Cancer With Extensive CNS MetastasesAlexander Andreev-Drakhlin, Maria Cabanillas, Behrang Amini, et al.
Diagnostics (Basel, Switzerland)|September 14, 2024
Assessing the Effectiveness of Selective RET Inhibitors in RET-Positive Cancers through Fluorodeoxyglucose Uptake AnalysisKalevi Kairemo, Homer A Macapinlac, Mohammed Gouda, et al.
JCO Precision Oncology|April 3, 2026
Living Guidelines for Tumor-Agnostic Therapies: A Pathway to Next-Generation Cancer TreatmentVivek Subbiah, Thomas K Oliver, Jim Palma, et al.
Acta Haematologica|March 13, 2026
Reconsidering Asparaginase in Leukemia TherapyMaria Frost, Vivek Subbiah, Branko Cuglievan, et al.
Pediatric Blood & Cancer|July 12, 2011
Gastric adenocarcinoma in children and adolescentsVivek Subbiah, Gauri Varadhachary, Cynthia E Herzog, et al.
Diagnostics (Basel, Switzerland)|April 5, 2017
An Assessment of Early Response to Targeted Therapy via Molecular Imaging: A Pilot Study of 3'-deoxy-3'[(18)F]-Fluorothymidine Positron Emission Tomography <sup>18</sup>F-FLT PET/CT in Prostate AdenocarcinomaKalevi Kairemo, Gregory C Ravizzini, Homer A Macapinlac, et al.
Diagnostics (Basel, Switzerland)|January 16, 2020
Early Response Assessment to Targeted Therapy Using 3'-deoxy-3'[(18)F]-Fluorothymidine (<sup>18</sup>F-FLT) PET/CT in Lung CancerKalevi Kairemo, Elmer B Santos, Homer A Macapinlac, et al.
Pathologica|May 21, 2025
From dominance to decline: can we reverse the trend in small molecule and TKI cancer therapies?Denis Horgan, Paul Hofman, Daniel Schneider, et al.
Case Reports in Oncology|February 23, 2019
Beyond KRAS: Practical Molecular Targets in Pancreatic AdenocarcinomaAlbert Grinshpun, Yonaton Zarbiv, Jason Roszik, et al.
Pageof 49

Showing results (121-130 of 487) with videos related to

Sort By:
Pageof 49
Mayo Clinic Proceedings|November 6, 2020
Patient-Centered, Physician-Investigator Friendly Pragmatic Phase Trial Designs-The 4P ModelDavid C Norris, Shiraj Sen, Roman Groisberg, et al.
JCO Precision Oncology|November 6, 2020
Systemic and CNS Activity of Selective RET Inhibition With Selpercatinib (LOXO-292) in a Patient With RET-Mutant Medullary Thyroid Cancer With Extensive CNS MetastasesAlexander Andreev-Drakhlin, Maria Cabanillas, Behrang Amini, et al.
Diagnostics (Basel, Switzerland)|September 14, 2024
Assessing the Effectiveness of Selective RET Inhibitors in RET-Positive Cancers through Fluorodeoxyglucose Uptake AnalysisKalevi Kairemo, Homer A Macapinlac, Mohammed Gouda, et al.
JCO Precision Oncology|April 3, 2026
Living Guidelines for Tumor-Agnostic Therapies: A Pathway to Next-Generation Cancer TreatmentVivek Subbiah, Thomas K Oliver, Jim Palma, et al.
Acta Haematologica|March 13, 2026
Reconsidering Asparaginase in Leukemia TherapyMaria Frost, Vivek Subbiah, Branko Cuglievan, et al.
Pediatric Blood & Cancer|July 12, 2011
Gastric adenocarcinoma in children and adolescentsVivek Subbiah, Gauri Varadhachary, Cynthia E Herzog, et al.
Diagnostics (Basel, Switzerland)|April 5, 2017
An Assessment of Early Response to Targeted Therapy via Molecular Imaging: A Pilot Study of 3'-deoxy-3'[(18)F]-Fluorothymidine Positron Emission Tomography <sup>18</sup>F-FLT PET/CT in Prostate AdenocarcinomaKalevi Kairemo, Gregory C Ravizzini, Homer A Macapinlac, et al.
Diagnostics (Basel, Switzerland)|January 16, 2020
Early Response Assessment to Targeted Therapy Using 3'-deoxy-3'[(18)F]-Fluorothymidine (<sup>18</sup>F-FLT) PET/CT in Lung CancerKalevi Kairemo, Elmer B Santos, Homer A Macapinlac, et al.
Pathologica|May 21, 2025
From dominance to decline: can we reverse the trend in small molecule and TKI cancer therapies?Denis Horgan, Paul Hofman, Daniel Schneider, et al.
Case Reports in Oncology|February 23, 2019
Beyond KRAS: Practical Molecular Targets in Pancreatic AdenocarcinomaAlbert Grinshpun, Yonaton Zarbiv, Jason Roszik, et al.
Pageof 49